Alphatec (NASDAQ: ATEC) — Perfil da empresa, notícias e dados financeiros
Alphatec designs products for spine surgery, focusing on innovative solutions to enhance patient outcomes.

Alphatec
Alphatec (NASDAQ:ATEC) is a company focused on the design, development, and marketing of products for the surgical treatment of spine disorders. With a commitment to improving patient outcomes, Alphatec's portfolio includes a wide range of solutions aimed at addressing the challenges faced by spine surgery professionals. Projects encompass innovative spinal fusion technologies, minimally invasive surgery techniques, and biologics, aiming to advance spinal care and enhance quality of life for patients. The company's objectives revolve around expanding its market presence, continually innovating its product line, and maintaining a strong focus on customer satisfaction and clinical excellence. Through rigorous research and development, Alphatec seeks to lead the way in providing state-of-the-art spine care solutions.
Resumo
Operações
Produtos e/ou serviços de Alphatec
- Spinal fusion technologies designed to enhance patient outcomes and surgeon experience.
- Minimally invasive surgery tools for improved precision and recovery in spinal procedures.
- 3D-printed interbody implants for enhanced spinal fusion and bone growth.
- Comprehensive spine surgery planning and navigation software for accurate implant placement.
- Advanced biologics for spinal fusion enhancement and bone healing acceleration.
- Patient-specific spinal instrumentation and implants for personalized surgery approaches.
equipe executiva do Alphatec
- Patrick S. MilesChairman, CEO & President
- J. Todd KoningExecutive VP & CFO
- Scott LishChief Operating Officer
- David P. SponselExecutive Vice President of Sales
- Craig E. HunsakerExecutive Vice President of People & Culture
- Robert JuddVP of Finance and Investor Relations & Controller
- Tyson Eliot MarshallGeneral Counsel & Corporate Secretary
- Ali ShorooghiSenior Vice President of Marketing & Medical Education
- Jonathan AllenExecutive Vice President of Commercial Operations
- Luiz PimentaChief Medical Officer
Principais indicadores financeiros
Resultados divulgados pela Alphatec, em USD.
- Cap. de mercado
- 1,8 bi
- Receita (TTM)
- 815,1 mi
- P/L
- —
- LPA (diluído, TTM)
- -0.7
- Dividend yield
- —
- Margem de lucro
- -13.5%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 764,2 mi | -82,1 mi | -143,4 mi | |
| 611,6 mi | -136,2 mi | -162,1 mi | |
| 482,3 mi | -173,4 mi | -186,6 mi | |
| 350,9 mi | -147 mi | -151,3 mi |